Literature DB >> 2422325

A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation.

I C Kilpatrick, M W Jones, O T Phillipson.   

Abstract

The application of a commercially available coulometric electrochemical detector to the automated HPLC analysis of some monoamines and their metabolites in microdissected areas of the rat nervous system is described. Apart from the stability and high sensitivity of the system, other appealing features of the technique are the facile sample preparation and long-term sample storage characteristics which show minimal analyte degradation. Basal values of some regional monoamine and metabolite concentration are listed together with a brief appendix that serves as a user's guide to the operation and maintenance of the detection system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422325     DOI: 10.1111/j.1471-4159.1986.tb08506.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  45 in total

1.  Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats.

Authors:  M Bubser; T Tzschentke; W Hauber
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

Authors:  Lori M Gorton; Marta G Vuckovic; Nina Vertelkina; Giselle M Petzinger; Michael W Jakowec; Ruth I Wood
Journal:  Behav Brain Res       Date:  2010-05-21       Impact factor: 3.332

3.  Basal Ganglia Dysfunction Contributes to Physical Inactivity in Obesity.

Authors:  Danielle M Friend; Kavya Devarakonda; Timothy J O'Neal; Miguel Skirzewski; Ioannis Papazoglou; Alanna R Kaplan; Jeih-San Liow; Juen Guo; Sushil G Rane; Marcelo Rubinstein; Veronica A Alvarez; Kevin D Hall; Alexxai V Kravitz
Journal:  Cell Metab       Date:  2016-12-29       Impact factor: 27.287

4.  Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.

Authors:  Kristin B Dupre; Corinne Y Ostock; Karen L Eskow Jaunarajs; Thomas Button; Lisa M Savage; William Wolf; Christopher Bishop
Journal:  Exp Neurol       Date:  2011-02-22       Impact factor: 5.330

5.  Influence of B vitamins on binding properties of serotonin receptors in the CNS of rats.

Authors:  K Dakshinamurti; S K Sharma; D Bonke
Journal:  Klin Wochenschr       Date:  1990-01-19

6.  Function and developmental origin of a mesocortical inhibitory circuit.

Authors:  Anna Kabanova; Milan Pabst; Markus Lorkowski; Oliver Braganza; Anne Boehlen; Negar Nikbakht; Leonie Pothmann; Ankita R Vaswani; Ruth Musgrove; Donato A Di Monte; Magdalena Sauvage; Heinz Beck; Sandra Blaess
Journal:  Nat Neurosci       Date:  2015-05-11       Impact factor: 24.884

7.  The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat.

Authors:  Nirmal Bhide; David Lindenbach; Margaret A Surrena; Adam A Goldenberg; Christopher Bishop; S Paul Berger; Melanie A Paquette
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

8.  Effect of domoic acid on metabolism of 5-hydroxytryptamine in rat brain.

Authors:  B Arias; M Arufe; M Alfonso; R Duran
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

9.  Dopamine function in the prefrontal cortex of the rat is sensitive to a reduction of tonic GABA-mediated inhibition in the thalamic mediodorsal nucleus.

Authors:  M W Jones; I C Kilpatrick; O T Phillipson
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

10.  Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

Authors:  Kristin B Dupre; Karen L Eskow; Christopher J Barnum; Christopher Bishop
Journal:  Neuropharmacology       Date:  2008-09-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.